0.77 USD
▲-0.03+3.02%
盘后 0.75 +0.98%
2026-08-03
市值
$2.67M
市盈率
—
EPS
-28.02
股息率
—
52 周区间
0.71 – 31.74
成交量
119.42K
Beta
-0.11
目标价
—
52W 低 0.7152W 高 31.74
价格走势
公司简介
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company’s product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of cancer-related anorexia; and ART12.11, a cocrystal composition of cannabidiol and tetramethylpyrazine for the treatment anxiety, depression, post-traumatic stress disorder PTSD, epilepsy and inso...